What do you need?


Online members portal


ABPI members can log in for bespoke content and services


Only Just Begun

Celebrating the history of the UK pharmaceutical industry in changing the lives of patients, and the people involved in its past, present and future

Play video


04 October 2018

ABPI responds to MHRA consultation on 'no deal' legislative proposals

The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would have to be modified in the event of the UK not securing a deal with the EU after the UK’s exit, with no Implementation Period.

04 October 2018

Diabetes Hothouse – call launched for digital health innovators

NHS England, the Association of the British Pharmaceutical Industry (ABPI) and the AHSN Network have joined forces to launch an ambitious new programme, connecting digital health innovators with pharmaceutical companies to explore new innovations that could help people living with diabetes.

02 October 2018

ABPI responds to Health Secretary speech at Conservative Party Conference

ABPI Chief Executive Mike Thompson welcomed the Health Secretary's announcements on genomics at Conservative Party Conference today. He talked about expanding the 100,000 Genomes Project, and highlighted the potential of genomics for both the early diagnosis and treatment of diseases. 

21 September 2018

ABPI responds to Avastin case judgment

The Court has today made a judgment on the use of Avastin to treat a condition called wet age-related macular degeneration (wet AMD).



01 October 2018

Nobel Prize in Physiology or Medicine: 5 key discoveries over the past 100 years

This year the Nobel Prize Committee has awarded the Physiology or Medicine prize to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation. This week we're highlighting four other discoveries over the past 100 years that have changed the face of modern medicine.

24 September 2018

New guidance notes on collecting adverse events, product complaints and special reporting situations during market research

The new ABPI/BHBIA Guidance notes on collecting adverse events, product complaints and special reporting situations during market research were published on 14 August 2018. The ABPI Pharmacovigilance Expert Network (PEN) have worked very closely with the British Healthcare Business Intelligence Association (BHBIA) on updating the Guidance.